플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): randomized double-blinded controlled trial.

Authors

Kim JB, Shin JW, Kang JY, Son CG, Kang W, Lee HW, Lee DS, Park YC, Cho JH.

Journal

J Ethnopharmacol.

Year

2014

Vol (Issue)

151(1)

Page

279-86.

doi

10.1016/j.jep.2013.10.033.

PMID

24239600

Url

http://www.ncbi.nlm.nih.gov/pubmed/24239600

MeSH

Adult
Aged
Double-Blind Method
Dyspepsia/drug therapy*
Female
Humans
Male
Medicine, East Asian Traditional
Middle Aged
Phytotherapy
Plant Preparations/therapeutic use*
Quality of Life*
Young Adult

Keywords

Complementary and alternative medicine; Functional dyspepsia; Hyang-Sa-Pyeong-Wi-San; Quality of Life

한글 키워드

보완대체의학; 기능성 소화불량; 향사평위산; 삶의 질

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Y

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:
Hyangaa-Pyeongwi san is the most well known description in Traditional Chinese Medicine for treating functional gastrointestinal disorders. Functional dyspepsia (FD) is a main concern of intimidating quality of life (QoL) in recent days. Although many medicines have been developed to improve FD symptoms as well as QoL, there are no potential drugs and treatments for FD. The aim of this study is to investigate the effects of Hyangaa-Pyeongwi san (HPS) on QoL of patients with FD.
METHODS:
This study was designed as a randomized, double blinded, placebo controlled, and parallel group trial. Participants received either placebo or HPS (9.68g of HPS at once, three times daily) for 4-weeks, and the efficacy evaluations were performed by assessing the Nepean Dyspepsia Index (NDI) and functional dyspepsia-quality of life (FD-QoL) at 0-, 4- and 8-weeks.
RESULTS:
Total of 170 patients participated and were randomly allocated into placebo or HPS groups. Total symptom score of NDI decreased after 4-weeks trial in both groups (p>0.05). HPS significantly improved QoL scores, especially in the area of 'interference and eat/drink' in NDI (p=0.0031) as well as 'liveliness status', 'role-functioning status', and total score in FD-QoL (p=0.026 for liveliness status and p=0.035 for role-functioning status). This significant improvement of FD-QoL had lasted for 4-weeks.
CONCLUSION:
HPS treatment is markedly effective in improving QoL in patients with FD. Moreover, we observed that this improvement had lasted for 4 weeks after finishing the trial through the follow-up study.

국문초록

Language

영어

첨부파일